This website uses cookies so that we can provide you with the best possible user experience. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team understand which areas of the site you find most interesting and useful.
Some questions
from our customers…
… what’s your question for us?
Case studies
Case study 1
Build trust to help innovation
Build trust to help innovation
Acting as trusted intermediary between sponsor & supplier
- Situation – Sponsor unhappy with supplier performance. Emotions clouding discussions.
- Solution – An impartial, root cause analysis identified that both parties were partially to blame on performance issues – implementation of improve supplier governance, with clearer responsibilities and simplified communication channels
Key Consideration
Ensure you keep a win-win environment , give a long term perspective to your relationship to vendors.
Key Consideration
Avoid single source, give a long term perspective to your relationship to vendors.
Case study 2
Clinical supplies category refresh
Changing the relationship using a procurement process driven category update
- Situation – Sponsor unhappy with supplier performance and single source situation driving lack of motivation on supplier side
- Solution – Market research, identification of 5 options, data driven assessment and implementation of a second clinical supply and distribution outsourced solution, including LN2 warehousing capabilities globally
Case study 3
Comparator usage optimisation
Reducing overall study budget
- Situation – comparators/reference drug overage and wastage worth over 1M$+/year.
- Solution – sale of unused product and implementation of an usage optimization solution (USA), identification of several options, data driven assessment and implementation of a second comparators and ancillaries sourcing solution.
Key Consideration
Think beyond product purchase cost and look at optimizing the overall product usage and wastage.
Key Consideration
You have to explain and demonstrate your vendor selection process to the competent authorities.
Case study 4
Compliance support
Ensuring regulatory requirements
- Situation – Health Authority GCP inspection for a study
- Solution – Presentation of supplier selection and management processes to authorities , detailing due diligence and risk assessment of suppliers involved – no non-compliance identified
Case study 5
Supply chain services for decentralized cell therapies
Helping develop a concept by finding suitable partners to develop a new set of services to serve hospital based cell therapy manufacturing
- Situation – next generation cell therapy start up looking for partners to manage their supply chain including new set of services not yet available
- Solution – Identification of actors in the field and engagement, including via a consortium approach (one can not do all), to co-develop new solutions under the supervision of the client
Key Consideration
Key Consideration
Data integration and technical expertise are key, common goals and aligned company cultures are essential.
Case study 6
Cell therapy Tracking System and beyond
Identifying the IT solution to build a customized solution
- Situation – next generation cell therapy startup looking for a IT platform to build their new approach to cell therapies
- Solution – Identification of key current and upcoming actors in the cell therapy field (CoC and CoI) field and engagement to co-develop a new solution starting with a strong recognized basis.
Case study 7
Medical device development support
Helping develop a inhaler device for a mid-size biotech
- Situation – make or buy strategy analysis, business continuity and IP focus. Identification of actors in the field and engagement based on key focuses
- Solution – identification of partner through procurement process allowing timely production start based on fully owned manufacturing license allowing second source manufacturing potential
Key Consideration
Keep in mind the importance of the long term business continuity (several sources), including sustainability impact and IP impact.